NCT00957671View on ClinicalTrials.gov

Anterior Pituitary Hormone Replacement in Traumatic Brain Injury

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Growth Hormone DeficiencyTraumatic Brain Injury
Interventions
DRUG

Recombinant human growth hormone

200 mcg daily for two months, followed by 400 mcg daily for two months followed by 600 mcg daily for term of treatment period (one year total)

Trial Locations (2)

77550

Transitional Learning Center, Galveston

77555

The University of Texas Medical Branch at Galveston, Galveston

All Listed Sponsors
collaborator

The Moody Foundation

OTHER

lead

The University of Texas Medical Branch, Galveston

OTHER

NCT00957671 - Anterior Pituitary Hormone Replacement in Traumatic Brain Injury | Biotech Hunter | Biotech Hunter